Metastatic melanoma options

Key messages

• There are many targeted agents in development for metastatic melanoma.
• New agents aim to increase the anti-tumour immune response – either by increasing activity of cytotoxic T cells, engineering tumour-specific T cells, redirecting T cells to the tumour, or shifting the microenvironment to a more immune-stimulating stage.